A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors

Lignende værker

• Epigenetic therapy with hydralazine and valproate associated to cisplatin chemoradiation in FIGO stage IIIB. A phase II study
  af: Candelaria, Myrna, et al.
  Udgivet: (2007)
• A proof-of-principle study of epigenetic therapy with hydralazine and magnesium valproate plus doxorubicin cyclophosphamide as neoadjuvant therapy for locally advanced breast cancer
  af: Arce, Claudia, et al.
  Udgivet: (2007)
• Histone acetylation and histone deacetylase activity of magnesium valproate in tumor and peripheral blood of patients with cervical cancer. A phase I study
  af: Chavez-Blanco, Alma, et al.
  Udgivet: (2005)
• Antineoplastic effects of the DNA methylation inhibitor hydralazine and the histone deacetylase inhibitor valproic acid in cancer cell lines
  af: Chavez-Blanco, Alma, et al.
  Udgivet: (2006)
• A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes
  af: Zambrano, Pilar, et al.
  Udgivet: (2005)